Hydrogel device protects rectum during prostate cancer radiotherapy

A new device that has just been cleared for commercial use by the US Food and Drug Administration offers men with prostate cancer who are undergoing radiotherapy some protection from collateral damage, specifically to the rectal tissues that are anatomically situated close to the prostate gland.

Medscape